AFP Examines Expansion Of Indian Drug Companies In South Africa

Agence France-Presse examines how Indian drug companies have infiltrated the South African market over the last few years in an effort to have a broader reach in Africa. India’s pharmaceutical industry is now the second largest in the world by volume, according to AFP.

“Unlike most multinational companies, India’s ‘big three’ pharmaceuticals – Ranbaxy, Cipla and Dr. Reddy’s – have carefully cultivated their local credentials by bringing South Africans into the top corporate echelons. … Cheap generic drugs have been the catalysts of that growth, and Africa has been a key market, buying 14 percent of India’s $8-billion pharmaceutical exports in 2009,” the news service writes. “Ranbaxy and Cipla have also won fans by slashing the price of anti-AIDS drugs … Providing discount generics has been big business and helped the Indian industry displace its Western rivals,” the article notes (Berger, 5/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.


KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.